Summary : A new study by Yale School of Public Health (YSPH) researchers suggests that the Pfizer-BioNTech vaccine was more than 91%…
Corona
-
-
AgrochemicalsCovid DrugsIndia
Researchers from CDRI working to develop two new Covid-19 drugs
by adminby adminSummary : A team of scientists led by chief scientist Ravishankar is working on two combinations to provide the safest medication to coronavirus patients.…
-
AgrochemicalsGlobal Market
Singapore approves Covid-19 vaccine boosters for age 12-17s
by adminby adminSummary : Singapore will extend its COVID-19 booster vaccination programme to adolescents aged 12 to 17 years from next month, its health…
-
CompaniesGlobal MarketPfizerPharma Science & Research
Pfizer and BioNTech publish data from two laboratory studies on COVID-19 vaccine-induced antibodies ability to neutralize SARS-CoV-2 Omicron variant
by adminby adminSynopsis : Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the publication of new results from two laboratory studies…
-
AgrochemicalsCovid Drugs
Placebo effect accounts for more than two-thirds of COVID-19 vaccine adverse events
by adminby adminSynopsis : The placebo effect is the well-known phenomenon of a person’s physical or mental health improving after taking a treatment with…
-
AgrochemicalsCovid DrugsIndia
Biophore India receives Licences from MPP to market Molnupiravir
by adminby adminSynopsis : Natco Pharma Limited and Biophore India Pharmaceuticals have received the license from the Medicines Patent Pool (MPP), Switzerland, to manufacture and…
-
Pharma Science & Research
Pfizer shares in vitro efficacy of novel COVID-19 oral treatment against Omicron Variant
by adminby adminSynopsis : Pfizer Inc. (NYSE: PFE) today shared results from multiple studies demonstrating that the in vitro efficacy of nirmatrelvir, the active…
-
IndiaPharma Science & Research
COVID-19: India supplies 5 lakh more Covaxin doses to Afghanistan
by adminby adminSynopsis: Bharat Biotech on Monday informed that India has supplied another batch of humanitarian assistance consisting of 5,00,000 doses of COVID-19 vaccine,…
-
AgrochemicalsIndia
Serum Institute CEO Hails WHO’s Approval of Covovax for Emergency Use
by adminby adminSynopsis- India-made Covovax on Friday became the ninth Covid-19 vaccine to receive WHO’s emergency use listing approval, with manufacturer Serum Institute of…
-
Synopsis- The provisional approval is for two doses of the paediatric Pfizer COVID-19 vaccine, given at least 21 days apart, the health…